Lexapro, Zoloft and Prozac are three of the most widely prescribed SSRIs (selective serotonin reuptake inhibitors) for depression and anxiety. They work the same basic way — increasing serotonin activity in the brain — and all three come as low-cost generics (escitalopram, sertraline and fluoxetine), so the practical differences come down to how long each stays in the body, how it tends to be tolerated, and which interactions to watch. On each drug's page we also layer an independent FDA recall-safety score and a live NADAC cost-per-dose, so you can weigh safety history and price alongside the clinical picture.
There's no single "best" SSRI — for depression and anxiety these three are broadly comparable in effectiveness, and the right choice is individualized. They differ mainly in half-life (fluoxetine is very long-acting; escitalopram and sertraline are roughly once-daily), in how the side effects tend to feel, and in interactions — but response and tolerability vary person to person. These are prescription-only medicines: which one and what dose is decided by your prescriber based on your symptoms, other medicines and how you respond, so do not start, stop, or switch on your own. This is general information, not medical advice — ask your prescriber or pharmacist.
| Lexapro escitalopram | Zoloft sertraline | Prozac fluoxetine | |
|---|---|---|---|
| Active ingredient | Escitalopram Oxalate | Sertraline Hydrochloride | Fluoxetine Hydrochloride |
| Our rating | 70/100 | 68/100 | Not yet rated |
| Typical price | $0.16 /mL | ~$1.09 /30 | $0.05 /mL |
| Half-life | ~27-32 hours (once daily) | ~26 hours (once daily) | Very long — 1-3 days (4-6 days with ongoing use); active metabolite norfluoxetine 4-16 days |
| General tolerability note | Typical SSRI effects — nausea, sleep changes, sexual side effects; generally well tolerated, but this varies by person | Typical SSRI effects; nausea or diarrhea is common early on and often settles with time | Typical SSRI effects; can be more activating (insomnia, jitteriness) for some people |
| Notable interactions | Never with MAO inhibitors; caution with other serotonergic drugs and with NSAIDs/aspirin/blood thinners (bleeding). Relatively few interactions overall | Never with MAO inhibitors; caution with other serotonergic drugs and with NSAIDs/aspirin/blood thinners (bleeding) | Never with MAO inhibitors (separate by several weeks); also pimozide and thioridazine; caution with other serotonergic drugs and NSAIDs/blood thinners — effects persist after stopping |
| Prescription? | Yes — prescription only | Yes — prescription only | Yes — prescription only |
| Good to know | Often chosen as a first-line SSRI — simple once-daily dosing and relatively few drug interactions; shares the class side effects and the boxed warning. | Widely used with a broad set of approved uses (depression, several anxiety disorders, PTSD, OCD, PMDD); GI upset is common in the first weeks. | Very long-acting with an active metabolite (norfluoxetine); tends to be more activating and self-tapers gently, but its interactions linger for weeks after stopping. |
Ratings are our independent FDA recall-safety score. General information, not medical advice.
Lexapro (escitalopram)
Often chosen as a first-line SSRI — simple once-daily dosing and relatively few drug interactions; shares the class side effects and the boxed warning.
Zoloft (sertraline)
Widely used with a broad set of approved uses (depression, several anxiety disorders, PTSD, OCD, PMDD); GI upset is common in the first weeks.
Prozac (fluoxetine)
Very long-acting with an active metabolite (norfluoxetine); tends to be more activating and self-tapers gently, but its interactions linger for weeks after stopping.
All three ease depression and anxiety by raising serotonin activity, and head-to-head studies don't crown a clear winner — choose by practical fit with your prescriber, not by a "strongest" label. Per MedlinePlus and their FDA labels, every SSRI including these three carries a BOXED WARNING that antidepressants can increase suicidal thoughts and behavior in children, teenagers and young adults (under 24), especially in the first weeks of treatment or after a dose change — anyone starting one should be watched closely for worsening mood or agitation and contact their prescriber right away if that happens. Never combine an SSRI with an MAO inhibitor (risk of serotonin syndrome), and use caution with other serotonergic drugs (triptans, tramadol, St. John's wort) and with NSAIDs, aspirin or blood thinners (higher bleeding risk). Don't stop abruptly — discontinuation symptoms like dizziness, mood changes and flu-like feelings are common, so your doctor tapers the dose; fluoxetine's very long half-life makes it self-taper more gently. This is general information, not medical advice — talk to your prescriber or pharmacist about which SSRI and dose fit you, and never start, stop, or switch on your own.